Warning: Undefined array key "file" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Sorafenib Tosylate

High Quality Sorafenib Tosylate CAS 284461-73-0 for Anti-Turmor

 

  • Sunan samfur:

    Sorafenib Tosylate

  • Kaddarori:

    White to off-white solid

  • Shiryawa:

    1 kg/Aluminum Bag or 25 kg/Drum

  • MOQ:

    1 kg

  • Ajiya:Wuri Mai Sanyi



Cikakkun bayanai

Tags

Bayanin Samfura

Sorafenib is a new multitarget oral drug for the treatment of cancer. It is used to treat gastrointestinal stromal tumors and metastatic kidney cells that do not respond to or tolerate standard therapies. It selectively targets certain protein receptors and is thought to act as a molecular switch during tumor growth. Its above indications have been granted "fast track" approval status by the FDA in the United States.

 

Siffofin

Appearance and properties: white to off-white solid
Density: 1.454 g/cm3
Melting point: 202-204°C
Boiling point: 523.3ºC at 760 mmHg
Flash point: 270.3ºC
Vapor pressure: 4.76E-11mmHg at 25°C

 

Aikace-aikace

Sorafenib is a novel, multi-targeted oral tumor agent for the treatment of inoperable or distant metastatic hepatocellular carcinoma.

 

Amfani

Muna da masana'antu masu inganci da yawa tare da haɗin gwiwa mai zurfi, wanda zai iya ba ku samfuran inganci da farashin gasa. Kuma muna iya ba da rangwamen kuɗi don sayayya mai yawa. Kuma muna ba da haɗin kai tare da ƙwararrun kamfanoni masu jigilar kaya, za su iya isar da samfuran cikin aminci da kwanciyar hankali ga hannunku. Lokacin bayarwa shine kimanin kwanaki 3-20 bayan tabbatar da biyan kuɗi.

 

Ƙayyadaddun bayanai

 

Product knowledge

1. Treatment of inoperable or distant metastatic liver tumor cells.
​2. Treatment of inoperable renal tumor cells.
​3. Treatment of locally relapsed or metastatic, progressively differentiated thyroid patients who no longer respond to radioiodine therapy.

 

Shipping da biya

 

FAQ

 

1. Shin ku masana'anta ne ko kamfani na kasuwanci?
Mu kamfani ne mai haɗa masana'antu da kasuwanci, samar da sabis na tsayawa ɗaya. Ana iya karɓar OEM.

 

2. Kuna samar da samfurori? Yana da kyauta ko kari?
Samfuran kyauta. Ana buƙatar biyan kuɗin jigilar samfurin ta gefen ku.

 

3. Kuna da wasu takaddun shaida masu alaƙa da kula da inganci?
ISO 9001: 2008 takardar shaida don tabbatar da inganci.

 

4. Menene zan bayar don samun zance?
Pls sanar da mu nau'in samfurin wanda kuke buƙata, adadin oda, adireshi da takamaiman buƙatu. Za a yi zance don bayanin ku cikin lokaci.

 

5. Wane irin hanyar biyan kuɗi kuka fi so? Wane irin sharuɗɗan ne ake karɓa?
Sharuɗɗan Isar da Karɓa: FOB, CFR, CIF, EXW;
Kudin Biyan Da Aka Karɓa: USD;
Nau'in Biyan Da Aka Karɓa: T/T, Western Union; Paypal, Tabbacin Kasuwanci.
Harshe Ana Magana: Turanci.

 

Idan kuna sha'awar samfuranmu, zaku iya zaɓar barin bayanin ku anan, kuma za mu tuntube ku nan ba da jimawa ba.


Ku rubuta sakonku anan ku aiko mana